AU6460100A - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
AU6460100A
AU6460100A AU64601/00A AU6460100A AU6460100A AU 6460100 A AU6460100 A AU 6460100A AU 64601/00 A AU64601/00 A AU 64601/00A AU 6460100 A AU6460100 A AU 6460100A AU 6460100 A AU6460100 A AU 6460100A
Authority
AU
Australia
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU64601/00A
Inventor
John Dixon
Philip Holt
Francis Ince
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca UK Ltd
Original Assignee
AstraZeneca UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca UK Ltd filed Critical AstraZeneca UK Ltd
Publication of AU6460100A publication Critical patent/AU6460100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
AU64601/00A 1999-08-18 2000-08-14 Pharmaceutical compositions Abandoned AU6460100A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9902936A SE9902936D0 (en) 1999-08-18 1999-08-18 Pharmaceutical compositions
SE9902936 1999-08-18
PCT/GB2000/003112 WO2001012191A2 (en) 1999-08-18 2000-08-14 Pharmaceutical compositions comprising a 7-(2-aminoethyl)-benzothiazolone and a glucocorticoid

Publications (1)

Publication Number Publication Date
AU6460100A true AU6460100A (en) 2001-03-13

Family

ID=20416694

Family Applications (1)

Application Number Title Priority Date Filing Date
AU64601/00A Abandoned AU6460100A (en) 1999-08-18 2000-08-14 Pharmaceutical compositions

Country Status (4)

Country Link
AR (1) AR025340A1 (en)
AU (1) AU6460100A (en)
SE (1) SE9902936D0 (en)
WO (1) WO2001012191A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2543858C (en) 2003-11-21 2014-04-15 Theravance, Inc. Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
TW200738658A (en) 2005-08-09 2007-10-16 Astrazeneca Ab Novel compounds
TW200745067A (en) 2006-03-14 2007-12-16 Astrazeneca Ab Novel compounds
TW200833670A (en) 2006-12-20 2008-08-16 Astrazeneca Ab Novel compounds 569
GB0702458D0 (en) 2007-02-08 2007-03-21 Astrazeneca Ab Salts 668
WO2009154557A1 (en) 2008-06-18 2009-12-23 Astrazeneca Ab Benzoxazinone derivatives acting as beta2-adrenoreceptor agonist for the treatment of respiratory disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9211172D0 (en) * 1992-05-27 1992-07-08 Fisons Plc Compounds

Also Published As

Publication number Publication date
WO2001012191A2 (en) 2001-02-22
SE9902936D0 (en) 1999-08-18
AR025340A1 (en) 2002-11-20
WO2001012191A3 (en) 2001-09-07

Similar Documents

Publication Publication Date Title
AU781269C (en) Pharmaceutical compositions
AU3192700A (en) Medicinal compositions
HUP0202513A2 (en) Betha-carboline pharmaceutical compositions
AU2001250420A1 (en) Pharmaceutical compositions
AU1071301A (en) Pharmaceutical compounds
GB0028088D0 (en) Pharmaceutical compositions
AU2001274307A1 (en) Pharmaceutical compositions
GB0001662D0 (en) Pharmaceutical compositions
AU3556400A (en) Pharmaceutical compositions
AU2005300A (en) Medicinal compositions
GB9923436D0 (en) Pharmaceutical compositions
AU1887401A (en) Medicinal composition
AU4328800A (en) Pharmaceutical formulation
AU1735001A (en) Cyclodextrin-containing pharmaceutical composition
AU6715600A (en) Pharmaceutical formulations
GB9904163D0 (en) Pharmaceutical compositions
AU4304400A (en) Novel pharmaceutical compositions comprising 2-isoxazole-8-aminotetralin derivatives
AU6460400A (en) Pharmaceutical compositions
AU5460800A (en) Pharmaceutical transdermal compositions
AU2001273919A1 (en) Pharmaceutical compositions
GB9911017D0 (en) Pharmaceutical compositions
AU2681500A (en) Rapidly-soluble compositions
AU4977300A (en) Pharmaceutical formulations
AU6460200A (en) Pharmaceutical compositions
AU1385801A (en) Pharmaceutical formulations

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase